Table 2.

Frequency of anti-Toxoplamsa IgG antibody in HIV/AIDS patients with different CD4+ T-lymphocyte counts

Immune function	Men		Women		Total
	No. cases	Seroprevalence (%)	No. cases	Seroprevalence (%)	No. cases	Seroprevalence (%)
Normala	40	10	10	0	50	8
Immunocompromisedb	97	9.3	32	25	129	13.2
Severely immunocompromisedc	53	3.8	20	10	73	5.5
Advanced AIDSd	6	0	1	0	7	0
Total	196	7.7	63	15.9	259	9.7

^aP>0.05, men vs women.

^bP<0.05, men vs women.

^cP>0.05, men vs women.

^dP>0.05, men vs women.